Clinical Trial Update: A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features [Phase 3]

View source ↗

Summary

Phase 3 trial of mifepristone vs placebo for major depressive disorder with psychotic features was terminated; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder with Psychotic Features

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Psychotic Depression, Severe Major Depression With Psychotic Features | Phase 3 | Status: TERMINATED | Results posted: 2017-02-16